Related Experiment Videos
Cellular camouflage: fooling the immune system with polymers.
1Department of Pathology and Laboratory Medicine, Albany Medical College, New York 12208, USA. mscottpath@aol.com
Current Pharmaceutical Design
|April 10, 1999
Summary
Camouflaging foreign cells with polymers like methoxypoly(ethylene glycol) [mPEG] reduces immune rejection in transfusions and transplants. This "stealth cell" technology offers a promising approach to prevent adverse immune responses to foreign cells.
Area of Science:
- Immunology
- Biomaterials Science
- Transplantation Medicine
Background:
- Immunological recognition of foreign cells is a critical challenge in transfusion and transplantation.
- Existing methods to prevent immune rejection are often highly specific and can be complex.
Purpose of the Study:
- To investigate the efficacy of globally camouflaging foreign cells using nonimmunogenic polymers, such as methoxypoly(ethylene glycol) [mPEG], to reduce immunological recognition.
- To explore the potential applications of this "stealth cell" technology in various medical contexts.
Main Methods:
- Modification of red blood cells (RBCs) and white blood cells (WBCs) with mPEG.
- In vitro assessment of antibody binding and immunogenicity.
- In vivo survival studies in animal models.
- Evaluation of T cell proliferation in response to foreign MHC molecules.
Main Results:
- mPEG-modified RBCs showed attenuated antibody binding and decreased immunogenicity, with normal in vitro and in vivo characteristics.
- Pegylation of WBCs, including antigen-presenting cells and T lymphocytes, prevented recognition of foreign class II molecules and T cell proliferation.
- The approach demonstrated potential in preventing immune recognition and adverse reactions.
Conclusions:
- Global surface camouflage of foreign cells with long-chain polymers like mPEG is an effective strategy to diminish immune responses.
- This technique has broad potential applications in transfusion medicine, graft-versus-host disease prevention, and transplantation to reduce acute tissue rejection.